FDA Inspection 1269298 — Aurisco Pharmaceutical Co., Ltd
The FDA completed an inspection of Aurisco Pharmaceutical Co., Ltd on March 21, 2025 in Tiantai, Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Tiantai, Taizhou (China)